Literature DB >> 16018647

Kadsuphilactones A and B, two new triterpene dilactones from kadsuraphilippinensis.

Ya-Ching Shen1, Yu-Chi Lin, Michael Y Chiang, Sheau Farn Yeh, Yuan-Bin Cheng, Chia-Ching Liao.   

Abstract

[structure: see text]. Two novel triterpene dilactones, kadsuphilactones A (1) and B (2), were isolated from the Taiwanese medicinal plant Kadsura philippinensis. The structures of 1 and 2 were elucidated on the basis of extensive spectroscopic methods, including two-dimensional NMR techniques, and confirmed by X-ray crystallographic analysis. Kadsuphilactone B (2) exhibited in vitro anti-HBV activity with IC(50) values of 6 microg/mL by HBsAg enzyme immunoassay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16018647     DOI: 10.1021/ol051155k

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Anti-RAFLS Triterpenoids and Hepatoprotective Lignans From the Leaves of Tujia Ethnomedicine Kadsura heteroclita (Xuetong).

Authors:  Mengyun Wang; Sai Jiang; Nusrat Hussain; Salman Zafar; Qingling Xie; Feibing Huang; Linxi Mao; Bin Li; Yuqing Jian; Wei Wang
Journal:  Front Chem       Date:  2022-05-10       Impact factor: 5.545

2.  Isolation, Structural Elucidation of Three New Triterpenoids from the Stems and Leaves of Schisandra chinensis (Turcz) Baill.

Authors:  Feng Qiu; Han Liu; Huan Duan; Pian Chen; Shao-Juan Lu; Guang-Zhong Yang; Xin-Xiang Lei
Journal:  Molecules       Date:  2018-07-04       Impact factor: 4.411

3.  Xuetonglactones A-F: Highly Oxidized Lanostane and Cycloartane Triterpenoids From Kadsura heteroclita Roxb. Craib.

Authors:  Nuzhat Shehla; Bin Li; Liang Cao; Jianping Zhao; Yuqing Jian; Muhammad Daniyal; Atia-Tul Wahab; Ikhlas A Khan; Duan-Fang Liao; Atta-Ur Rahman; M Iqbal Choudhary; Wei Wang
Journal:  Front Chem       Date:  2020-01-21       Impact factor: 5.221

4.  Two New 3,4;9,10-seco-Cycloartane Type Triterpenoids from Illicium difengpi and Their Anti-Inflammatory Activities.

Authors:  Chuntong Li; Fengmin Xi; Junling Mi; Zhijun Wu; Wansheng Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-15       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.